Compare CAII & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAII | PALI |
|---|---|---|
| Founded | 2026 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.6M | 359.0M |
| IPO Year | 2026 | 2019 |
| Metric | CAII | PALI |
|---|---|---|
| Price | $10.01 | $1.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.22 |
| AVG Volume (30 Days) | 38.2K | ★ 3.2M |
| Earning Date | N/A | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $9.90 | $1.42 |
| 52 Week High | $10.01 | $2.86 |
| Indicator | CAII | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 67.40 | 30.46 |
| Support Level | $9.92 | N/A |
| Resistance Level | N/A | $2.19 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 100.00 | 8.99 |
Collective Acquisition Corp II is a blank check company.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.